EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Botulinum Toxin Complex Serotype B-Okra Exerts Systemic Toxicity via the Oral Route by Disrupting the Intestinal Epithelial Barrier

Chiyono Morimoto, Sho Amatsu iD, Takuhiro Matsumura iD, Masahiko Zuka, Yukako Fujinaga

Toxins · 04.09.2025 · 17 (9) · 443

DOI: 10.3390/toxins17090443 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxins, online erschienen am 04.09.2025. Verfasst von Chiyono Morimoto und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bacteriology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa 920-8640, Japan. Hauptthemen laut MEDLINE: Intestinal Mucosa, Botulinum Toxins, Botulinum Toxins, Type A. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science (JSPS), Japan Society for the Promotion of Science (JSPS) KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Botulinum toxin (BoNT) causes flaccid paralysis by blocking the release of neurotransmitters. BoNTs associate with neurotoxin-associated proteins to form medium and large progenitor toxin complexes. The large progenitor toxin complex serotype A-62A (L-PTC/A-62A) specifically targets intestinal M cells for invasion, whereas large progenitor toxin complex serotype B-Okra (L-PTC/B-Okra) is mainly taken up by enterocytes and exhibits higher toxicity via the oral route. Hemagglutinin (HA) is a neurotoxin-associated protein that promotes BoNT absorption from the intestine and has carbohydrate-binding and barrier-disrupting activities. In this study, we established an in vitro reconstitution and purification system for recombinant L-PTC/B-Okra and created a recombinant L-PTC/B-Okra mutant rL-PTC/B-KA with carbohydrate-binding activity but not barrier-disrupting activity. rL-PTC/B-KA showed significantly reduced oral toxicity. Our results demonstrate that the B-Okra toxin disrupts the epithelial barrier of enterocytes and exerts oral toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intestinal MucosaBotulinum ToxinsBotulinum Toxins, Type AAnimalsAdministration, OralEnterocytesHumansMiceSerogroupCaco-2 CellsHemagglutininsMale

Stichwörter der Autor:innen

Clostridium botulinumE-cadherinbotulinum toxinbotulinum toxin complexepithelial barrierhemagglutininin vitro reconstitution

Substanzen

Botulinum ToxinsBotulinum Toxins, Type ArimabotulinumtoxinBHemagglutinins

Autor:innen und Institutionen

  • Department of Bacteriology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa 920-8640, Japan.
  • Department of Forensic Medicine and Pathology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa 920-8640, Japan.

ORCID-Profile: Sho Amatsu, Takuhiro Matsumura

Förderung

  • Japan Society for the Promotion of Science (JSPS)
  • Japan Society for the Promotion of Science (JSPS) KAKENHI

Zitieren

APA

Morimoto, C., Amatsu, S., Matsumura, T., Zuka, M., & Fujinaga, Y. (2025). Botulinum Toxin Complex Serotype B-Okra Exerts Systemic Toxicity via the Oral Route by Disrupting the Intestinal Epithelial Barrier. Toxins, 17(9), 443. https://doi.org/10.3390/toxins17090443

Vancouver

Morimoto C, Amatsu S, Matsumura T, Zuka M, Fujinaga Y. Botulinum Toxin Complex Serotype B-Okra Exerts Systemic Toxicity via the Oral Route by Disrupting the Intestinal Epithelial Barrier. Toxins. 2025;17(9):443. doi:10.3390/toxins17090443

BibTeX
@article{Morimoto2025,
  author = {Morimoto, Chiyono and Amatsu, Sho and Matsumura, Takuhiro and Zuka, Masahiko and Fujinaga, Yukako},
  title = {Botulinum Toxin Complex Serotype B-Okra Exerts Systemic Toxicity via the Oral Route by Disrupting the Intestinal Epithelial Barrier},
  journal = {Toxins},
  year = {2025},
  volume = {17},
  number = {9},
  pages = {443},
  doi = {10.3390/toxins17090443}
}
Kostenlos starten →